IPCA LABORATORIES LTD. - 524494 - Board Meeting Outcome for Standalone And Consolidated Q3FY25 Results & Press Release

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer

1271.2000 -17.70 (-1.37%)

NSE Oct 31, 2025 15:50 PM

27.60% Fall from 52W High

Volume: 106.4K

Ipca Laboratories Ltd.

13 Feb 2025

1271.20

-1.37%

Board Meeting

IPCA LABORATORIES LTD. - 524494 - Board Meeting Outcome for Standalone And Consolidated Q3FY25 Results & …

BSE India

Standalone and Consolidated Q3FY25 Results & Press Release

More from Ipca Laboratories Ltd.

Recommended

Market closes lower, Bharat Electronics' Q2 net profit beats Forecaster estimates by 15%

Trendlyne Marketwatch | 31 Oct 2025, 04:01PM

The thrill fades, but fundamentals improve: Inside India’s selective bull market

The Baseline | 30 Oct 2025, 12:36PM

IPCA Labs’ domestic formulations business to drive growth